Update in cutaneous manifestations of COVID-19: Special populations

Samantha Polly; Inga M Muser; Anthony P Fernandez

doi:10.3949/ccjm.90a.22013

Update in cutaneous manifestations of COVID-19: Special populations

Cleve Clin J Med. 2023 Jan 3;90(1):43-52. doi: 10.3949/ccjm.90a.22013.

Authors

Samantha Polly¹, Inga M Muser², Anthony P Fernandez³

Affiliations

¹ Complex Medical Dermatology Fellow, Department of Dermatology, Cleveland Clinic, Cleveland, OH.
² Resident Physician, Department of Pediatrics, Cleveland Clinic, Cleveland, OH.
³ Director of Medical Dermatology, WD Steck Chair of Clinical Dermatology, Departments of Dermatology and Pathology, Cleveland Clinic; Assistant Professor of Clinical Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH fernana6@ccf.org.

PMID: 36596595
DOI: 10.3949/ccjm.90a.22013

Abstract

Cutaneous abnormalities were among the first clinical findings reported in patients infected with SARS-CoV-2 at the onset of the COVID-19 pandemic, but the significance was initially unclear. Correlations have since been drawn between many of these cutaneous eruptions and their diagnostic or prognostic value. Additionally, COVID-19 vaccines have generated acute and delayed cutaneous reactions with which clinicians should be familiar. In this narrative review, we update the cutaneous abnormalities associated with COVID-19 infection for pediatric and non-White populations, and common cutaneous reactions to COVID-19 vaccines.

Publication types

Review

MeSH terms

COVID-19 Vaccines
COVID-19* / complications
Child
Exanthema*
Humans
Pandemics
SARS-CoV-2

Substances

COVID-19 Vaccines